Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer’s disease
Nicolai Franzmeier, Anna Dewenter, Lukas Frontzkowski, et al.
Science Advances (2020) Vol. 6, Iss. 48
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Alzheimer disease
David S. Knopman, Hélène Amieva, Ronald C. Petersen, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 1528
Four distinct trajectories of tau deposition identified in Alzheimer’s disease
Jacob W. Vogel, Alexandra L. Young, Neil P. Oxtoby, et al.
Nature Medicine (2021) Vol. 27, Iss. 5, pp. 871-881
Open Access | Times Cited: 551
Tauopathies: new perspectives and challenges
Yi Zhang, Kaimin Wu, Yang Liu, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 187
Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
Joseph Therriault, Tharick A. Pascoal, Firoza Z Lussier, et al.
Nature Aging (2022) Vol. 2, Iss. 6, pp. 526-535
Open Access | Times Cited: 170
Targeting neuroinflammation in Alzheimer’s disease: from mechanisms to clinical applications
Yu Liu, Zizhen Si, Chen-Jun Zou, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 4, pp. 708-708
Open Access | Times Cited: 111
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Alexa Pichet Binette, Nicolai Franzmeier, Nicola Spotorno, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 87
Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight
Jacob W. Vogel, Nick Corriveau‐Lecavalier, Nicolai Franzmeier, et al.
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 10, pp. 620-639
Closed Access | Times Cited: 80
Tau deposition patterns are associated with functional connectivity in primary tauopathies
Nicolai Franzmeier, Matthias Brendel, Leonie Beyer, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 73
Biomarker-based staging of Alzheimer disease: rationale and clinical applications
Joseph Therriault, Suzanne E. Schindler, Gemma Salvadó, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 4, pp. 232-244
Closed Access | Times Cited: 58
Brain connectomics: time for a molecular imaging perspective?
Arianna Sala, Aldana Lizarraga, Silvia Paola Caminiti, et al.
Trends in Cognitive Sciences (2023) Vol. 27, Iss. 4, pp. 353-366
Open Access | Times Cited: 55
Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease
Nicolai Franzmeier, Amir Dehsarvi, Anna Steward, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 22
Amyloid-associated hyperconnectivity drives tau spread across connected brain regions in Alzheimer’s disease
Sebastian Niclas Roemer, Franziska Wagner, Lisa Evangelista, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 782
Closed Access | Times Cited: 5
Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals
Davina Biel, Matthias Brendel, Anna Rubinski, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 104
Staging of Alzheimer’s disease: past, present, and future perspectives
Joseph Therriault, Eduardo R. Zimmer, Andréa Lessa Benedet, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 9, pp. 726-741
Open Access | Times Cited: 67
Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study
Rachel F. Buckley, Adrienne O’Donnell, Emer R. McGrath, et al.
Annals of Neurology (2022) Vol. 92, Iss. 1, pp. 11-22
Open Access | Times Cited: 61
Earlier Alzheimer’s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading
Lukas Frontzkowski, Michael Ewers, Matthias Brendel, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55
Medial Temporal Lobe Networks in Alzheimer's Disease: Structural and Molecular Vulnerabilities
Robin de Florès, Sandhitsu R. Das, Long Xie, et al.
Journal of Neuroscience (2022) Vol. 42, Iss. 10, pp. 2131-2141
Open Access | Times Cited: 54
Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer’s disease
Jeremy A. Tanner, Leonardo Iaccarino, Lauren Edwards, et al.
Brain (2022) Vol. 145, Iss. 12, pp. 4489-4505
Open Access | Times Cited: 51
Tau protein spreads through functionally connected neurons in Alzheimer’s disease: a combined MEG/PET study
Deborah N. Schoonhoven, Emma M. Coomans, Ana P. Millán, et al.
Brain (2023) Vol. 146, Iss. 10, pp. 4040-4054
Open Access | Times Cited: 35
ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels
Anna Steward, Davina Biel, Anna Dewenter, et al.
JAMA Neurology (2023) Vol. 80, Iss. 12, pp. 1295-1295
Open Access | Times Cited: 34
The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework
Arthur C. Macedo, Cécile Tissot, Joseph Therriault, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 8, pp. 1171-1178
Open Access | Times Cited: 33
Associations between sex, body mass index and the individual microglial response in Alzheimer’s disease
Gloria Biechele, Boris‐Stephan Rauchmann, Daniel Janowitz, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Alpha synuclein co-pathology is associated with accelerated amyloid-driven tau accumulation in Alzheimer’s disease
Nicolai Franzmeier, Sebastian Niclas Roemer, Alexander Bernhardt, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study
Justin S. Sanchez, Bernard Hanseeuw, Francisco Lopera, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 45
Personality Associations With Amyloid and Tau: Results From the Baltimore Longitudinal Study of Aging and Meta-analysis
Antonio Terracciano, Murat Bilgel, Damaris Aschwanden, et al.
Biological Psychiatry (2021) Vol. 91, Iss. 4, pp. 359-369
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top